Medicine

Take a Pill for Bedbugs

The new way to kill bedbugs: take a pill and go to bed and let them bite you. A few days later, they die. The technique is known as xenointoxication, which sounds like intergalactic beer pong but in medical pathology is Greek for “poisoning the guest.” In Dr. Sheele’s study, over 60 percent of the […]

Take a Pill for Bedbugs Read More »

Using Rattlesnakes Fight Cancer

Popular Science: An Irish company is using four American diamondback rattlesnakes in a new clinical trial that will test snake venom as a treatment for cancer. The snakes, which hail from the Albuquerque BioPark, will be allowed to bite something and have their venom extracted humanely. The venom contains proteins that will be extracted and

Using Rattlesnakes Fight Cancer Read More »

The End of Doctors?

Gigaom: A pair of Indiana University researchers has found that a pair of predictive modeling techniques can make significantly better decisions about patients’ treatments than can doctors acting alone. How much better? They claim a better than 50 percent reduction in costs and more than 40 percent better patient outcomes. The idea behind the research,

The End of Doctors? Read More »

Virtually See the Doctor

If you live in Detroit, and you need to go to the doctor, you now have a new option: a computer screen in Rite Aid. American Medical News: When patients walk into a NowClinic at any one of nine Detroit-area Rite Aid pharmacies, they can choose among multiple physicians to see about what’s ailing them.

Virtually See the Doctor Read More »

Making Generic Medicine Hip

Business Week: Help Remedies is fast becoming a case study in the triumph of branding. Co-founders Richard Fine and Nathan Frank are doing for generic drugs what American Apparel did for plain T-shirts: wrapping them in cool with every trick in the downtown branding playbook, from hip packaging to absurdist videos to youth targeting. Fine,

Making Generic Medicine Hip Read More »

UnTapped Market: Adult ADHD

AlterNet: There is good news and bad news about attention deficit/hyperactivity disorder (ADHD) — that is, if you’re a drug company. The bad news is the kid market has peaked out with 4.5 million U.S. children now carrying the label. The good news is adult ADHD is an emerging market. In fact, adult ADHD, with

UnTapped Market: Adult ADHD Read More »